alpha-fluoro-beta-alanine has been researched along with 5-fluorodihydrouracil in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armand, JP; Bernadou, J; Lopez, A; Malet-Martino, MC; Martino, R | 1 |
Diasio, RB; Schuetz, JD; Sommadossi, JP; Wallace, HJ | 1 |
Hoshi, A; Iigo, M; Kuretani, K; Nakamura, A | 1 |
Almond, MR; Chestnut, WG; Harrington, JA; Porter, DJ; Spector, T; Tanoury, G | 1 |
Bachert, P; Becker, M; Dietz, A; Knopp, MV; Rudat, V; Schlemmer, HP; van Kaick, G; Vanselow, B; Wannenmacher, M; Weidauer, H; Wollensack, P; Zuna, I | 1 |
Ciccolini, J; Etienne-Grimaldi, MC; Fischel, JL; Formento, P; Milano, G | 1 |
Hirakawa, K; Kim, WY; Nakata, B | 1 |
Hanauske, A; Hilger, RA; Krauss, J; Kredtke, S; Makris, L; Mende, B; Scheulen, ME; Scigalla, P; Strumberg, D; Thyssen, D; Urrea, PD | 1 |
8 other study(ies) available for alpha-fluoro-beta-alanine and 5-fluorodihydrouracil
Article | Year |
---|---|
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance.
Topics: beta-Alanine; Fluorine; Fluorouracil; Humans; Magnetic Resonance Spectroscopy; Radioisotopes; Urea | 1985 |
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Topics: Animals; Antineoplastic Agents; beta-Alanine; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred Strains; Thymidylate Synthase | 1985 |
Excretion of 1-hexylcarbamoyl-5-fluorouracil in urine of mice.
Topics: Animals; beta-Alanine; Female; Fluorouracil; Mice; Mice, Inbred Strains | 1981 |
Enzymatic elimination of fluoride from alpha-fluoro-beta-alanine.
Topics: Alanine; Alanine Transaminase; Amino Acid Sequence; Animals; Antimetabolites, Antineoplastic; beta-Alanine; Catalysis; Chemical Phenomena; Chemistry, Physical; Enzyme Activation; Enzyme Inhibitors; Fluorides; Fluorouracil; Glyoxylates; Kinetics; Liver; Malondialdehyde; Molecular Sequence Data; Rats; Stereoisomerism; Substrate Specificity; Transaminases | 1995 |
Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; beta-Alanine; Biotransformation; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorine; Fluorouracil; Head and Neck Neoplasms; Humans; Isotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged | 1999 |
Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.
Topics: Antineoplastic Agents; beta-Alanine; Cell Line, Tumor; Dihydrouracil Dehydrogenase (NADP); Dose-Response Relationship, Drug; Floxuridine; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Inhibitory Concentration 50; Keratinocytes; Syndrome; Thymidine Phosphorylase | 2004 |
Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; beta-Alanine; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Middle Aged; Oxonic Acid; Stomach Neoplasms; Tegafur | 2007 |
Pharmacokinetic study of S-1.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Area Under Curve; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fasting; Fluorouracil; Food; Gastric Acidity Determination; Half-Life; Humans; Hydrogen-Ion Concentration; Oxonic Acid; Pantoprazole; Pyridines; Tegafur; Triazines; Uracil | 2009 |